Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: A new way to fund healthcare in developing Asia

Susann Roth, senior social development specialist, Asian Development Bank, explains why the ADB is committed to doubling health sector investments by 2020.

A healthy population is the backbone of a strong workforce productivity, which in turn supports inclusive growth and sustainable development. In recent decades, public and private sector investments to drive economic growth and trade have brought tremendous gains to countries in Asia and the Pacific.

But investments in health have lagged behind those in other sectors.

As part of the Sustainable Development Goals, almost every country in the region has committed to universal health coverage (UHC) and providing equitable access to quality care without undue financial hardship.

To deliver on the UHC promise, though, it is essential that countries tackle weak social security systems, focus on persistent pockets of poverty and inequality, enable the private sector to deliver affordable and quality health services and commodities, and reduce out-of-pocket expenditures.

Aging populations foreshadow escalating health care costs in the near future, where both communicable and non-communicable diseases are growing threats. There are also new health risks associated with migration and the effects of climate change.

Unfortunately, the development assistance that in the past had bolstered health financing in Asia and the Pacific region is rapidly declining.

Countries lose eligibility for donor funding as they leave behind their low-income status. Top donors and development partners such as the GAVI Alliance and the Global Fund to Fight AIDS, tuberculosis and malaria are also concentrating on low-income countries.

To make matters even worse, bilateral grant resources and concessional funds are decreasing too.

Asian governments thus struggle to find new ways to mobilize funds to close the huge health financing gap.

Health is part of “social” infrastructure. According to accounting firm PwC, social infrastructure represents around 20% of the region’s total infrastructure investment needs, which are in the trillions of dollars.

To help countries in developing Asia increase health sector funding, ADB is committed to doubling health sector investments to 5% of its total portfolio by 2020. This includes private and public sector loans, and most of this lending will come from ordinary capital resources since many of ADB’s developing member countries have graduated already or will soon be graduating from concessional and grant financing.

Moreover, non-concessional lending is part of the new health sector portfolio being developed by ADB’s Private Sector Operations Department.

Asia’s private health sector is growing rapidly, with many companies aiming to take advantage of emerging markets. The fact that companies and investors are looking at opportunities to invest in the health sector is reflected in ADB’s new health bond, the first ever in this sector issued by a multilateral development bank and launched last March.

The health bond highlights ADB’s commitment to the health sector. It also shows that in today’s increasingly volatile financial environment, investors want low-risk, high-impact investments in health.

The health bond is similar in structure to ADB’s successful water and green bonds, which mobilise funds from financial markets for ordinary capital resources lending in priority sectors. Initially, the health bond will mobilize about US$100 million for health lending in ADB’s sovereign and non-sovereign operations.

In the private sector, the funds raised will contribute to investing in companies that seek high impact on quality, affordability, and accessibility of health services and commodities. ADB has developed an ex-ante due diligence framework to ensure that private sector investments support UHC.

The health bond also targets the public sector, where ADB is working with several lower middle-income countries on strengthening primary health care services, making sure they’re available first of all, and then ready to provide them.

The new funds will be welcomed in countries like India, Kazakhstan, Papua New Guinea or Uzbekistan, where ADB is focused on improving primary and integrated care, health sector management and urban health.

This includes primary and secondary care infrastructure, supporting an enabling environment for public private partnerships, basic medical equipment, digital health infrastructure, staff capacity development, and skills development.

In other words, the health bond opens the door to badly needed long-term financing for health projects. ADB’s developing member countries can expand both public and private spending on health with funding via financial markets.

This is crucial given that the development journey of Asia’s new middle-income countries has not concluded. In fact, it is far from over – especially in health.

Posted on: 07/06/2017 UTC+08:00


News

Union Medical Healthcare, the largest aesthetic medical service provider in Hong Kong, has said that it intends to change the use of the proceeds of its IPO.
Hong Kong-listed Hua Han Health Industry Holdings says that it is on course for the examination into the negative reports from Emerson Analytics last year to be completed by Grant Thornton by the end of the third quarter.
Hang Seng-listed China Medical & HealthCare Group expects to record a significant decrease in the loss attributable to the shareholders of the company for the year ended 30 June.
Beijing-based Symbow Medical, which develops surgical navigation devices, has raised Rmb120 million (US$17.8 million) Series A funding led by Huayi Capital. National Emerging Industry Guidance Fund, Shandong Buchang Pharmaceuticals, and Sangel Capital all participated.
International Healthway Corporation (IHC), a Singapore-listed integrated healthcare services and facilities provider, has warned that it expects to post a loss for the first and second quarters of the year. “The loss is mainly attributable to operating loss for 1Q2017 and impairment of certain receivables for 2Q2017, respectively,” the company said in a statement.
Medical glove manufacturer Careplus Group plans to raise M$18.9 million (US$4.4 million) via a private placement of shares. The group plans to sell 48.3 million shares at an indicative price of R$0.39 per share. RHB Investment Bank is managing the deal.
Private investment firm TE Asia Healthcare Partners and the Mother Teresa of Calcutta Medical Centre (MTCMC) in Pampanga have agreed to establish a Ps500 million (US$9.9 million) cancer treatment and management centre. The hospital is owned and operated by Silvermed Corporation.
Medical centre operator Primary Health Care has confirmed guidance for the year at the lower end of its guidance with expected net profits of A$92 million (US$73 million). It also flagged up a write down of A$575 million against its medical centres as the division has been underperforming.



Analysis

In what is starting to resemble a comedy of errors, Wenzhou Kangning Hospital, the largest private psychiatric specialty care service provider in China, is having to start work yet again for its A-share offering.
Singapore-based private equity firm Quadria Capital is expanding its holdings in the region with investments into Vietnam and Singapore from its third investment vehicle, Quadria Capital Fund. Financial details were not disclosed for either transaction.
Mental health is a growing issue for expats; workers and their employers, as well as those relocating independently, according to a recent research study by Aetna International. Expatriate mental health: breaking the silence and ending the stigma, calls for businesses and individuals to take more pre-emptive action to combat the problem, to ensure expats have the vital support they need when relocating or working away from their home country.
A new programme, launched by the Chinese Stroke Association (CSA) and the American Stroke Association (ASA) is aiming to improve the treatment for, and prevention of, cardiovascular and stroke events by helping hospitals and providers consistently adhere to the latest scientific treatment guidelines.
Brisbane-based Oventus has had a good week. First and foremost the sleep disorder device manufacturer has just completed the first tranche of capital raising. It has raised A$6.5 million (US$4.9 million) in a placement of shares at A$0.36 per share. A second tranche to raise A$0.5 million will follow subject to shareholder approval. Bell Potter is managing the deal.
A new report from QBE Insurance, Australia's largest global insurer, reveals that 22% of healthcare companies in Hong Kong have suffered from legal and regulatory compliance issues over the past 12 months. The Risks of Regret report looks at both current and future business challenges and opportunities, and how well-prepared companies are to deal with risks.
“The Asia-Pacific region presents lucrative opportunities for multinational pharmaceutical firms that treat diabetes,” says BMI Research in Singapore in a new report on healthcare in Asia. Fuelled by rapid urbanisation, nutrition transition and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity. Asia’s large population and rapid economic development have made it an epicentre of the epidemic, with India and China the key hotspots in the region, it explains.
Susann Roth, senior social development specialist, Asian Development Bank, explains why the ADB is committed to doubling health sector investments by 2020.


AON

HealthInvestor Asia Summit

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices